Skip to content

The effect of gastrocnemius dry needling in individuals with patellofemoral pain syndrome

The effect of adding gastrocnemius dry needling to conventional exercise therapy program on pain and function in individuals with patellofemoral pain syndrome: A randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240204060899N1
Enrollment
38
Registered
2024-06-01
Start date
2024-06-08
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patellofemoral pain syndrome. Patellofemoral disorders

Interventions

Intervention 1: Intervention group: Individuals in this group receive real dry needling of the gastrocnemius muscle in addition to the basic treatment. Dry needling is applied to the participants for

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
17 Years to 45 Years

Inclusion criteria

Inclusion criteria: Pain in the anterior part of the knee or the posterior part or border of the patella on one side, which is caused or aggravated by at least two of the following activities: prolonged sitting, prolonged kneeling, squatting, running, hopping, climbing or descending from the stairs Age between 17 and 45 years Presence of at least one trigger point in the gastrocnemius muscle of the involved side Positive glide patella test Presence of symptoms for at least 3 months The average pain intensity in the last week is more than 3 out of 10 based on the VAS scale

Exclusion criteria

Exclusion criteria: Radiological findings that indicate osteoarthritis History of knee injury, including ligament sprain, meniscus injury, or other intra-articular disorders Sensitivity when touching the patella tendon or Pes anserinus muscle tendon History of knee fracture, patellar dislocation, or lower limb surgery during the past year Existence of musculoskeletal disorders such as disc protrusion or spondylolisthesis, severe structural disorder of the lower limb such as hip or knee osteoarthritis, having a prosthesis Existence of metabolic or neurological disorders such as diabetes, radicular pain or sensory disturbances Existence of systemic diseases or connective tissue disorders Contraindications of dry needling, such as cardiovascular and coagulation problems, pregnancy, cancer and fear of needles The experience of receiving dry needling so far for any part of the body Receiving physiotherapy treatment for knee pain in the last three months

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: At the beginning of the study (before the start of the intervention) - 4 weeks after receiving the intervention (the end of the intervention) - One month after the end of the intervention (follow-up). Method of measurement: Visual Analogue Scale questionnaire.

Secondary

MeasureTime frame
Disability. Timepoint: At the beginning of the study (before the start of the intervention) - 4 weeks after receiving the intervention (the end of the intervention) - One month after the end of the intervention (follow-up). Method of measurement: Kujala questionnaire.;Ankle range of motion. Timepoint: At the beginning of the study (before the start of the intervention) - 4 weeks after receiving the intervention (the end of the intervention) - One month after the end of the intervention (follow-up). Method of measurement: Goniometer.;Step down test score. Timepoint: At the beginning of the study (before the start of the intervention) - 4 weeks after receiving the intervention (the end of the intervention) - One month after the end of the intervention (follow-up). Method of measurement: The number of going down the stairs in the Step down test.;Modify star excursion test score. Timepoint: At the beginning of the study (before the start of the intervention) - 4 weeks after receiving the intervention (the end of the intervention) - One month after the end of the intervention (follow-up). Method of measurement: Reaching distance in the Modified star excursion test with the tape measure.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Moghadasi Chevinlee

Iran University of Medical Sciences

hosseinmghch@gmail.com+98 51 4722 4364

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026